PAX8 is a transcription factor that plays critical roles in organ development and cancer biology. During embryonic development, PAX8 serves as a master regulator for thyroid, kidney, and genitourinary tract differentiation 1. In the kidney, PAX8 regulates the maturation of cystine transporter gene SLC3A1 expression, with PAX8 doubling SLC3A1 expression levels, contributing to proper amino acid reabsorption in the proximal tubule 2. PAX8 expression is increased in primitive ducts during renal dysplasia, suggesting involvement in aberrant kidney development 3. In thyroid cancer, PAX8 functions are context-dependent. The PAX8-GLIS3 fusion protein demonstrates oncogenic properties by activating the Sonic Hedgehog pathway, increasing proliferation and tumor formation 4. Additionally, PAX8-PPARG gene fusions produce oncoproteins found in follicular thyroid carcinomas, acting as dominant-negative inhibitors of wild-type PPAR-γ 5. METTL3-mediated regulation of PAX8 through m6A modification influences thyroid cancer differentiation and chemosensitivity 6. PAX8 is also expressed in metastatic renal cell carcinoma, where PAX8-myc signaling activation occurs in pancreatic metastases 7. These findings demonstrate PAX8's dual role as both a developmental regulator and cancer-associated factor.